Wednesday, September 23, 2009

Who you gonna call?

Editors of some medical journals are using "ghostbusting" to fight the number of articles coming from ghostwriters with ties to drug companies. Articles are being billed as the work of "independent academic authors" instead of the work of company-sponsored writers, resulting in articles that are more a part of a company's marketing scheme than scholarly work. Definitely a study of the acquistion and editorial stages of the publishing process.

No comments:

Post a Comment